Chromoblastomycosis (CBM) is a chronic subcutaneous mycosis caused by traumatic
implantation of many species of black fungi. Due to the refractoriness of some cases and …

Chromoblastomycosis (CBM) is a chronic granulomatous mycosis caused by dematiaceous
fungi that affects cutaneous and subcutaneous tissues. The standard antifungal drug for …

BACKGROUND Black fungi of the Herpotrichiellaceae family are agents of
chromoblastomycosis and phaeohyphomycosis. There are few therapeutic options for these …

Chromoblastomycosis (CBM) is a neglected human implantation mycosis caused by several
dematiaceous fungal species. Currently available therapy is usually associated with …

Chromoblastomycosis is a subcutaneous mycosis for which there is no treatment of choice
but rather, several treatment options, with low cure rates and many relapses. The choice of …

Chromoblastomycosis is one of the most important implantation (subcutaneous) mycoses in
the world. In recent years, the most significant advances against this disease have been …

Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by genera of
melanized fungi: Fonsecaea, Cladophialophora, Phialophora, Exophiala, and …

Chromoblastomycosis is a chronic mycosis that affects the skin and subcutaneous tissues
caused by several genera of dematiaceous fungi. There is not a treatment of choice. Thus …

Objective To describe the clinical aspects of chromoblastomycosis (CBM) presented by
patients who had received incomplete antifungal treatment before consultation. Methods A …

Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous
tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous …